Short description
A biopharmaceutical company focused on the discovery and development of new antimicrobial drugs
Description
Replidyne is a specialty pharmaceutical company focused on developing and commercializing innovative anti-infective products.
The company is building its development pipeline based on both its proprietary DNA replication technology and in-licensing efforts.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Louisville, Colorado, United States, North America
Founded on
January 1, 2000
Closed on
February 26, 2009
Exited on
June 28, 2006
Went public on
June 28, 2006
Stock symbol
RDYN
Non-profit?
No
Acquired?
No
Employees count
1001-5000
Investors
Noaccessforu, Noaccess, Noway Youcantaccess, Noaccess
Sign in for full access